{{Rsnum
|rsid=1396485
|Gene=COMMD10
|Chromosome=5
|position=116176655
|Orientation=plus
|GMAF=0.2971
|Gene_s=COMMD10
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 25.2 | 72.1
| HCB | 3.0 | 11.9 | 85.1
| JPT | 2.7 | 16.2 | 81.1
| YRI | 57.2 | 40.0 | 2.8
| ASW | 33.9 | 42.9 | 23.2
| CHB | 3.0 | 11.9 | 85.1
| CHD | 0.0 | 13.1 | 86.9
| GIH | 2.0 | 24.8 | 73.3
| LWK | 41.8 | 45.5 | 12.7
| MEX | 3.4 | 39.7 | 56.9
| MKK | 22.1 | 42.9 | 35.1
| TSI | 3.0 | 18.0 | 79.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=7E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}